| Analysis | Samples | Factors | Units |
|---|---|---|---|
| GC POSITIVE ION MODE | 47_3_1 | Group:E3_control | APOE genotype:E3/E3 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_10 | Group:E3_control | APOE genotype:E3/E3 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_11 | Group:E3_control | APOE genotype:E3/E3 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_12 | Group:E3_control | APOE genotype:E3/E3 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_2 | Group:E3_control | APOE genotype:E3/E3 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_3 | Group:E3_control | APOE genotype:E3/E3 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_4 | Group:E3_control | APOE genotype:E3/E3 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_9 | Group:E3_control | APOE genotype:E3/E3 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_13 | Group:E3_proinflammatory | APOE genotype:E3/E3 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_14 | Group:E3_proinflammatory | APOE genotype:E3/E3 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_15 | Group:E3_proinflammatory | APOE genotype:E3/E3 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_16 | Group:E3_proinflammatory | APOE genotype:E3/E3 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_5 | Group:E3_proinflammatory | APOE genotype:E3/E3 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_6 | Group:E3_proinflammatory | APOE genotype:E3/E3 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_7 | Group:E3_proinflammatory | APOE genotype:E3/E3 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_3_8 | Group:E3_proinflammatory | APOE genotype:E3/E3 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_1 | Group:E4_control | APOE genotype:E4/E4 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_10 | Group:E4_control | APOE genotype:E4/E4 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_12 | Group:E4_control | APOE genotype:E4/E4 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_2 | Group:E4_control | APOE genotype:E4/E4 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_3 | Group:E4_control | APOE genotype:E4/E4 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_4 | Group:E4_control | APOE genotype:E4/E4 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_9 | Group:E4_control | APOE genotype:E4/E4 | Treatment:Control | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_13 | Group:E4_proinflammatory | APOE genotype:E4/E4 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_14 | Group:E4_proinflammatory | APOE genotype:E4/E4 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_15 | Group:E4_proinflammatory | APOE genotype:E4/E4 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_16 | Group:E4_proinflammatory | APOE genotype:E4/E4 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_6 | Group:E4_proinflammatory | APOE genotype:E4/E4 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_7 | Group:E4_proinflammatory | APOE genotype:E4/E4 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
| GC POSITIVE ION MODE | 47_4_8 | Group:E4_proinflammatory | APOE genotype:E4/E4 | Treatment:Proinflammatory | Fractional Enrichment (adjusted for natural abundance) |
Return to study ST002451 main page
Download data matrix(APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge (Part 2 of 3) GC POSITIVE ION MODE)
- Metabolomics Workbench
|